Sutro Biopharma: Revolutionising biologics R&D using biochemical protein synthesis




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Sutro Biopharma: Revolutionising biologics R&D using biochemical protein synthesis
Released on: May 31, 2012. © PharmaTelevision Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this episode of PharmaTelevision News Review, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton speaks with William J Newell, Chief Executive Officer at Sutro Biopharma,
  • Summary
  • Transcript
  • Participants
  • Company
In this episode of PharmaTelevision News Review, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton speaks with William J Newell, Chief Executive Officer at Sutro Biopharma,
In this interview, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton speaks with William J Newell, Chief Executive Officer at Sutro Biopharma,
William J Newell
Chief Executive Officer
Sutro Biopharma
Sutro Biopharma
Sutro Biopharma, Inc. is a biopharmaceutical company that uses its patented Open Cell Free Synthesis (OCFS) technology to develop next- generation protein therapeutics for the treatment of human disease.